首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3- d ]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
【24h】

The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3- d ]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles

机译:5-芳基烷基氨基和5-哌嗪基部分在7-氨基吡唑并[4,3-d]嘧啶核上对腺苷A 1 和A 2A 受体的影响亲和力和选择性

获取原文
           

摘要

Lucia Squarcialupi a , Marco Betti a , Daniela Catarzi a , Flavia Varano a , Matteo Falsini a , Annalisa Ravani b , Silvia Pasquini b , Fabrizio Vincenzi b , Veronica Salmaso c , Mattia Sturlese c , Katia Varani b , Stefano Moro c* & Vittoria Colotta a* a Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica , Università di Firenze , Sesto Fiorentino , Italy ; b Dipartimento di Scienze Mediche, Sezione di Farmacologia , Università di Ferrara , Ferrara , Italy ; c Molecular Modeling Section (MMS), Dipartimento di Scienze del Farmaco , Università di Padova , Padova , Italy CONTACT Vittoria Colotta vittoria. colotta@unifi. it Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Università di Firenze , Via Ugo Schiff, 6 , 50019 Sesto Fiorentino , Italy ; Stefano Moro stefano. moro@unipd. it Molecular Modeling Section (MMS), Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5 , 35131 Padova , Italy Supplemental data for this article can be accessed here New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A1 and/or A2A receptor subtypes. On the whole, the novel derivatives 1 – 24 shared scarce or no affinities for the off-target hA2B and hA3 ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (Ki =?150?nM) and the best selectivity for the hA2A AR while the 5-benzylamino-substituted 5 displayed the best combined hA2A (Ki =?123?nM) and A1 AR affinity (Ki =?25?nM). The 5-phenethylamino moiety (compound 6 ) achieved nanomolar affinity (Ki =?11?nM) and good selectivity for the hA1 AR. The 5-(N4-substituted-piperazin-1-yl) derivatives 15 – 24 bind the hA1 AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.
机译:露西亚(Lucia Squarcialupi) a ,马可·贝蒂(Marco Betti a ),丹妮拉·卡塔兹(Daniela Catarzi) a ,弗拉维亚·瓦拉诺(Flavia Varano) a ,Matteo Falsini a ,安娜丽莎·拉瓦尼 b ,西尔维娅·帕斯奎尼 b ,Fabrizio Vincenzi b ,维罗妮卡·萨尔玛索 c ,Mattia Sturlese c ,Katia Varani b ,Stefano Moro c * 和Vittoria Colotta a * a 意大利佛罗伦萨大学塞斯托·菲奥伦蒂诺大学神经科学,心理学,药物和儿童保健领域药物与营养保健科; b 意大利费拉拉费拉拉大学药理学系医学科学系; c 意大利帕多瓦大学帕多瓦大学药物科学系分子建模科(MMS)联系Vittoria Colotta vittoria。 colotta @统一。佛罗伦萨大学神经科学,心理学,药物和儿童保健领域,药物和营养保健科,意大利,塞斯托·菲奥伦蒂诺,地址:Via Ugo Schiff,6,邮编:50019;斯特凡诺·莫罗·斯特凡诺。 moro @ unipd。意大利帕多瓦大学药物科学系分子建模部门(MMS),通过意大利3135131帕多瓦市的Marzolo 5,可在此处访问本文的补充数据。新的7-氨基-2-苯基吡唑啉[4,3-d]合成了在5位上被芳基(烷基)氨基和4-取代的哌嗪-1-基部分取代的嘧啶衍生物,其目标是针对人(h)腺苷A 1 和/或A 2A受体亚型。总体而言,新型衍生物1-24对脱靶hA 2B 和hA 3 AR的亲和力很少或没有亲和力。 5-(4-羟基苯乙氨基)-衍生物12对hA 2A AR具有良好的亲和力(K i =?150?NM)和最佳选择性,而5 -苄基氨基取代的5表现出最佳的组合hA 2A (K i =?123?nM)和A AR亲和力(K i =?25?nM)。 5-苯乙基氨基部分(化合物6)达到纳摩尔亲和力(K i =?11?NM)并且对hA AR具有良好的选择性。 5-(N 4 -取代的哌嗪-1-基)衍生物15-24结合hA 1 AR亚型,其亲和力在高纳摩尔范围内。进行了基于结构的分子建模研究,以使用分子对接研究和相互作用能指纹(IEF)分析从分子的角度合理化实验性结合数据。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号